ArticleFrontiers in oncology2022

The α-RECIST (RECIST 1.1 Combined With Alpha Fetoprotein): A Novel Tool for Identifying Tumor Response of Conversion-Radiotherapy for Unresectable Hepatocellular Carcinoma Before Hepatectomy.

Ying Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.